U.S. Food and Drug Administration
CV Sciences and UC San Diego Publish Study of Cannabidiol Efficacy in Treating Nicotine Dependence
CV Sciences, Inc. (San Diego, CA) has announced progress toward its goal of developing and commercializing a CBD-based pharmaceutical to treat nicotine addiction in smokeless tobacco users. The company, in collaboration with researchers from the University of California, San Diego (UC San Diego), published a preclinical study demonstrating the efficacy of chronic CBD treatment in ...
AHPA Updates Guidance on Major Food Allergens in Response to FASTER Act
The American Herbal Products Association (AHPA) has published a revised version of the guidance document titled “Compliance with the Food Allergen Labeling and Consumer Protection Act (FALCPA) for Marketers of Chinese Herbal Products” to include the requirements of the recently adopted Food Allergy Safety, Treatment, Education and Research Act of 2021 (FASTER Act), which adds sesame to ...
New Draft Legislation Sets Safe Level of Consumption for CBD Products
New draft legislation includes a provision directing the U.S. Food and Drug Administration (FDA) to set a safe level of consumption for CBD products. The provision is part of a broader bill introduced by Senator Chuck Schumer (D-NY) that would decriminalize cannabis at the federal level. “Setting a safe level of consumption for CBD products ...
Nutrasource Receives U.S. Patent for GMO Testing Method
Nutrasource Pharmaceutical and Nutraceutical Services (Canada) has announced the reception of a USTPO (United States Patent and Trademark Office) on “Methods for detecting genetically modified organisms” for the IGEN certification program. The International Genetically Modified Organism (GMO) Evaluation and Notification program verifies label claims about the presence of GMOs in products and ingredients. Today, regulations ...
FDA Is Not Looking to “Throw Out DSHEA,” Says ODSP’s Welch
By Janet Poveromo During the American Herbal Products Association’s (AHPA) 9th Botanical Congress held virtually on May 24, Cara Welch, acting director of the Office of Dietary Supplements Programs (ODSP), U.S. Food and Drug Administration (FDA), told industry members that the FDA is not “looking to throw out DSHEA (Dietary Supplement Health and Education Act of ...
Bipartisan Legislation Introduced Would Create Regulatory Pathways for Use of Hemp-derived CBD in Dietary Supplements and Conventional Food
On May 19, Senators Ron Wyden and Jeff Merkley (D-OR) and Senator Rand Paul (R-KY) introduced bipartisan legislation that would protect public health by providing legal clarity in the hemp and hemp-derived cannabidiol (CBD) product marketplace. The Hemp Access and Consumer Safety Act of 2021 would amend the Federal Food, Drug and Cosmetic Act (FD&CA) ...
NAI Becomes First Company to Meet New SSCI Benchmarking Standards
Natural Alternatives International (NAI, Carlsbad, CA) has become the first company to meet new safety and benchmarking standards created by the Supplement Safety & Compliance Initiative (SSCI). The announcement follows a more than five-year effort by the world’s leading nutritional supplement retailers—including Walmart and GNC—in collaboration with the Natural Products Association (NPA) and its members, to ...
100th Meeting of the Dietary Supplement Trade Associations Commemorated
On April 26, four of the leading trade organizations representing the dietary supplement industry commemorated the 100th meeting of the Dietary Supplement Trade Associations (DSTA). More than 10 years ago, the American Herbal Products Association (AHPA), the Consumer Healthcare Products Association (CHPA), the Council for Responsible Nutrition (CRN), and the United Natural Products Alliance (UNPA) began ...
FDA Warns Selling of Topical CBD Products Violates FD&C Act
On March 22, the U.S. Food and Drug Administration (FDA) stated that it has issued warning letters to two companies for selling topical pain relief products labeled as containing cannabidiol (CBD) in ways that violate the Federal Food, Drug and Cosmetic Act (FD&C Act). Specifically, the warning letters addressed the illegal marketing of unapproved drugs ...
CRN Applauds House Resolution Recognizing Vitamin D for Decreasing the Severity of COVID-19
The Council for Responsible Nutrition (CRN) said it applauds U.S. Representative Glenn Grothman (R-WI) for introducing a House Resolution (H. Res. 116) that recognizes the potential role vitamin D may play in decreasing the severity of COVID-19. The resolution calls on the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listings:
